Albumin-Adjusted Serum Calcium Levels Higher with Tumor Malignancy

Share this content:

the Cancer Therapy Advisor take:

Albumin-adjusted serum calcium was reported to be significantly greater in women with malignant tumors, according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.

Participants in this study included 514 women who underwent resection at Wake Forest University Baptist Medical Center (July 2009-June 2013) for pelvic masses. The patients were divided into a “training” set and a “testing” set (to identify data associations and to provide confirmation of these associations, respectively).

Results showed women with malignant masses had significantly greater levels of albumin-adjusted serum calcium levels compared to those with benign masses (P=0.0004).

High normocalcemia (ie, an albumin-adjusted serum calcium ≥10 mg/dL) was reported in 53% of women with malignant tumors compared with 12% in those with benign tumors. Furthermore, the high normocalcemia correlated to an increased risk of malignancy of approximately 14-fold.

The study suggests serum albumin and calcium could be an economic and sensitive method to predict malignancy of tumors in women with pelvic masses.

Albumin-Adjusted Serum Calcium Levels Higher with Tumor Malignancy
Albumin-adjusted serum calcium was reported to be significantly greater in women with malignant tumors.
1Section on Gynecologic Oncology, Wake Forest Baptist Medical Center 2Ob/Gyn, Wake Forest Baptist Medical Center 3Truven Health Analytics 4Population Health, University of North Dakota ↵*Corresponding Author: Gary G. Schwartz, Population Health, University of North Dakota, 501 N.
READ FULL ARTICLE From cebp.aacrjournals.org

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs